| P50 | author | Sarah Larney | Q44338034 |
| | Madeline K Mahowald | Q86916074 |
| P2093 | author name string | Nickolas D Zaller | |
| | Timothy P Flanigan | |
| | Curt G Beckwith | |
| | Nicholas Scharff | |
| P2860 | cites work | Outcomes of treatment for hepatitis C virus infection by primary care providers | Q24601722 |
| | An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases | Q24632766 |
| | The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 |
| | Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. | Q34294185 |
| | Estimating progression to cirrhosis in chronic hepatitis C virus infection. | Q34389608 |
| | Is severe liver disease a common outcome for people with chronic hepatitis C? | Q34619377 |
| | A 25-year study of the clinical and histologic outcomes of hepatitis C virus infection and its modes of transmission in a cohort of initially asymptomatic blood donors | Q36379288 |
| | Screening for HCV infection in jails | Q36983871 |
| | A simple strategy to identify acute hepatitis C virus infection among newly incarcerated injection drug users | Q37015619 |
| | Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis | Q37045826 |
| | Chronic hepatitis C virus (HCV) disease burden and cost in the United States | Q37148328 |
| | Impact of new therapeutics for hepatitis C virus infection in incarcerated populations | Q37419326 |
| | Viral hepatitis and injection drug use in Appalachian Kentucky: a survey of rural health department clients | Q37463420 |
| | Hepatitis C seroprevalence among prison inmates since 2001: still high but declining. | Q37525298 |
| | Epidemiology of hepatitis B and C viruses: a global overview | Q37685594 |
| | Fifteen million people on antiretroviral treatment by 2015: treatment as prevention | Q38063142 |
| | Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States☆☆☆ | Q39844102 |
| | Exploratory study of oral combination antiviral therapy for hepatitis C. | Q42987725 |
| | End-stage liver disease in a state prison population | Q43039878 |
| | Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence | Q43419544 |
| | Notes from the field : hepatitis C virus infections among young adults--rural Wisconsin, 2010. | Q45357595 |
| | Hepatitis C virus infection among adolescents and young adults:Massachusetts, 2002-2009. | Q45366817 |
| | Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system | Q47313217 |
| | A missed opportunity: hepatitis C screening of prisoners | Q81266513 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | epidemiology | Q133805 |
| | Hepatitis C virus | Q708693 |
| | birth cohort | Q64532946 |
| P304 | page(s) | e69-74 | |
| P577 | publication date | 2014-04-17 | |
| P1433 | published in | American Journal of Public Health | Q4744266 |
| P1476 | title | Epidemiology of hepatitis C virus in Pennsylvania state prisons, 2004-2012: limitations of 1945-1965 birth cohort screening in correctional settings. | |
| P478 | volume | 104 | |